# FDA 483 - Robert S. Call, M.D. - March 25, 2021

Source: https://www.keypedia.com/records/483/robert-s-call-md/d121c180-3a38-410c-a07f-8edf2e0ca861

> FDA 483 for Robert S. Call, M.D. on March 25, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robert S. Call, M.D.
- Inspection Date: 2021-03-25
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - East II
- Summary: An FDA inspection of Robert S. Call, M.D., a clinical investigator in Richmond, VA, revealed two significant observations. The firm failed to conduct an investigation according to the approved plan, specifically by missing required safety and laboratory assessments for a subject. Additionally, the firm did not maintain adequate and accurate case histories, as evidenced by unreported adverse events and concomitant medications.

## Related Documents

- [483 - 2022-10-19](https://www.keypedia.com/records/483/robert-s-call-md/88f0715c-692e-4216-9e15-1febe591bc26)

## Related Officers

- [investigator](https://www.keypedia.com/people/john-dan/8a8c42e4-66ec-438d-868e-f32461f9026c)

Company: https://www.keypedia.com/companies/robert-s-call-md/ff9844fc-3148-4764-8217-f077121ae86e

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-ii/a9ab7e08-db36-4350-a7d7-6a61dc61250e